Cigna drops coverage of GLP-1 obesity drugs for its own employees

Cigna has removed coverage for GLP-1 obesity medications for its own staff members. This decision comes as the cost of weight-loss drugs has been decreasing throughout 2026. Simultaneously, there is a broader trend of employers reducing their coverage for these specific medications. The move reflects a shift in how companies manage the availability of weight-loss treatments despite the falling market prices of the drugs involved in these healthcare plans.